Cite
Financial toxicity in patients with advanced solid malignancies participating in early-phase clinical trials
MLA
Julia Blanter, et al. “Financial Toxicity in Patients with Advanced Solid Malignancies Participating in Early-Phase Clinical Trials.” Journal of Clinical Oncology, vol. 40, Oct. 2022, p. 267. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........caa5036ccaf65da7e65666f299d57b88&authtype=sso&custid=ns315887.
APA
Julia Blanter, Michael Werner, Melanie Wain Kier, Olivia Hapanowicz, Muhieddine Itani, Maham Ahmad, Mandy DeMerchant, Joseph Paul Eder, Matt D. Galsky, Ashley Hammad, Paula King, Michael Lachowicz, Natalie Lucas, Thomas Urban Marron, Gary Shelton, Kathy Wu, Suzanne Xu, Patricia LoRusso, Erin Wysong Hofstatter, & Deborah Blythe Doroshow. (2022). Financial toxicity in patients with advanced solid malignancies participating in early-phase clinical trials. Journal of Clinical Oncology, 40, 267.
Chicago
Julia Blanter, Michael Werner, Melanie Wain Kier, Olivia Hapanowicz, Muhieddine Itani, Maham Ahmad, Mandy DeMerchant, et al. 2022. “Financial Toxicity in Patients with Advanced Solid Malignancies Participating in Early-Phase Clinical Trials.” Journal of Clinical Oncology 40 (October): 267. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........caa5036ccaf65da7e65666f299d57b88&authtype=sso&custid=ns315887.